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Fatty acids (FA) modify DNA methylation in vitro, but limited information is available on whether 
corresponding associations exist in vivo and reflect any short-term effect of the diet. Associations 
between global DNA methylation and FAs were sought in blood from lactating infants (LI; n = 49) and 
adult males (AMM; n = 12) equally distributed across the three conventional BMI classes. AMM provided 
multiple samples at 2-hour intervals during 8 hours after either a single Western diet-representative 
meal (post-prandial samples) or no meal (fasting samples). Lipid/glucose profile, HDAC4 promoter and 
PDK4 5’UTR methylation were determined in AMM. Multiple regression analysis revealed that global 
(in LI) and both global and PDK4-specific DNA methylation (in AMM) were positively associated with 
eicosapentaenoic and arachidonic acid. HDAC4 methylation was inversely associated with arachidonic 
acid post-prandially in AMM. Global DNA methylation did not show any defined within-day pattern that 
would suggest a short-term response to the diet. Nonetheless, global DNA methylation was higher in 
normal weight subjects both post-prandially and in fasting and coincided with higher polyunsaturated 
relative to monounsaturated and saturated FAs. We show for the first time strong associations of DNA 
methylation with specific FAs in two human cohorts of distinct age, diet and postnatal development 
stage.
The consumption of high-fat diets and alterations in lipid metabolism are associated with metabolic diseases 
and cancer1–3. In vitro data indicate that very low density lipoproteins (VLDL) and specific fatty acids (FAs) can 
change DNA methylation patterns4–7. These data, together with the known association of global DNA hypometh-
ylation with cancer (reviewed by Kulis and Esteller8), metabolic syndrome9 and the post-rupture atherosclerotic 
lesion10, and of DNA hypermethylation with early-stage atherosclerosis11,12, suggest that dietary lipids may exert 
pathological effects at least in part by imposing pathological DNA methylation profiles. If so, associations should 
be detectable between DNA methylation and specific FAs, yet the topic has received little attention to date.
Another pending issue is whether such associations reflect short- or long-term responses to the diet. Mid- and 
long-term high-fat dietary supplementation can change DNA methylation profiles in mammals13,14. Epigenetic 
short-term effects of the diet could be equally relevant, as the frequent transitions from pre-prandial/fasting to 
post-prandial states that are experienced by humans, may result in corresponding frequent oscillations between 
fasting- and post-prandial-specific epigenetic marks in at least selected loci in the genome. If so, it is conceivable 
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that any error-prone diet-driven oscillations may lock selected loci in a pathogenic chromatin state. For example, 
locking in a fasting-specific state may exacerbate a pre-existing thrifty genotype15.
In the present work, we assessed whether any association exists between whole peripheral blood DNA meth-
ylation and specific FAs and lipids in two distinct human cohorts - lactating infants and adult men - and whether 
those associations are rapidly modified in the postprandial state.
Results
Associations between DNA methylation and FAs in the lactating infant (LI) cohort. We first 
asked whether any association existed between global DNA methylation and specific FAs in whole peripheral 
blood. To that end, we interrogated a cohort of 49 Mexican lactating infants of both sexes. A description of the 
lactating infant cohort is presented in Supplementary Table 1. Sex, age at sampling, weight at birth, normalized 
weight gain - i.e. difference between the weight at sampling and at birth divided by the birth-to-sampling time 
(days) - whole peripheral blood FAs and global DNA methylation were the available variables for that cohort. 
When grouped by degree of saturation and percent-normalized, FAs showed a non-significant tendency to asso-
ciate inversely (saturated and monounsaturated FAs or SFAs and MUFAs, respectively) or positively (polyunsatu-
rated FAs or PUFAs) with DNA methylation (Supplementary Table 2.1). A multiple regression analysis adjusting 
for the above mentioned variables only revealed significant positive associations of global DNA methylation with 
normalized (% of all FAs) n-3 PUFA eicosapentaenoic acid (EPA; C20:5) and the n-6 PUFA arachidonic acid 
(AA; C20:4) among all detected FAs, with a noticeably stronger (higher Beta) association with EPA (Table 1). 
Although the estimation of the effects was not the primary aim of the study, the adjusted R2 indicates that EPA 
and AA explain ~17% of the variation in DNA methylation in the presented model. Furthermore, although DNA 
methylation changes with age16, we failed to detected any corresponding association between these two parame-
ters in the LI cohort (Supplementary Table 2.1). However, a handful of FAs were associated with age but not with 
sex (Supplementary Table 3). Notably, age accounted for nearly half of the variability of the sum of the SFA and 
MUFA C22:0 and C14:1 (p = 0.0015, adjusted R2 = 0.49) and the latter FAs were not associated with DNA meth-
ylation (p = 0.184, adjusted R2 = 0.04).
DNA methylation trend across the sampling period in adult men (AMM). The observation that 
global DNA methylation was associated with specific FAs in LI, prompted us to ask whether those associations 
were reproducible in an entirely distinct cohort and whether they were dynamically responsive to the diet. These 
questions were addressed in the AMM subjects, for which a complete metabolic and anthropometric profile was 
obtained, in addition to global and gene-specific DNA methylation data.
A total of 12 men entered and completed the study. A description of the AMM subjects is presented in 
Supplementary Table 4. The AMM subjects underwent a repeated blood draw procedure across an 8-hour period 
(see Methods), which is schematically shown in Fig. 1. Four subjects represented each of the normal weight, 
Variable Beta t p adjusted R2
C20:4 (AA) 0.0848 2.1084 0.0420 0.1683
C20:5 (EPA) 0.9867 2.3512 0.0384
Table 1.  Significant associations of FAs with global DNA methylation (dependent variable) in the LI 
cohort. Beta values indicate the change in % 5mdC per one-point increase in percent FA. Non-significant 
associations are shown in Supplementary Table 2.1.
Figure 1. AMM subject sampling scheme. Five consecutive, same-day blood samples were obtained from a 
total of 12 subjects in two prandial conditions: fasting (FD) and post-prandial (PD). The 10 AM blood sample 
represented the baseline for each day. A total of 120 samples were obtained and analyzed (60 per prandial 
condition).
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overweight and obese groups (BMI < 25, 25–30 and >30, respectively). The comparison between BMI groups 
showed expected significant differences in body weight, waist and hip circumference (WC and HC, respectively), 
waist-to-height ratio (WHtR) and systolic blood pressure (SBP). Meanwhile, age, height, waist-to-hip ratio 
(WHR) and diastolic blood pressure (DPB) showed no differences (Supplementary Table 4).
We hypothesized that total blood FA-dependent and/or lipid-dependent trends in global DNA methylation - 
i.e. an increase or decrease relative to 10 AM sample baseline, whether transient or stable throughout the 8 h 
sampling period - would be observed. However, a highly variable and not identifiable DNA methylation pattern 
across the sampling period was observed in the PD or FD sets - i.e. no significant difference between the 10AM 
baseline and any other time point or between the maximum and minimum values within any of the 6 sets (3 PD, 
3 FD) could be detected (ANOVA and Scheffé's post hoc test; Fig. 2 upper panels). Noticeably, the variability (SD) 
in the 5 average values (one for each time point) of the normal weight subjects was 3–5-fold lower compared to 
the other two BMI classes in both PD and FD (p < 0.001 in all comparisons with the normal weight set; Bartlett’s 
test).
Associations between DNA methylation and metabolic parameters in AMM. Based on the lack 
of any time-dependent global DNA methylation pattern and with the aim of optimising measurement accuracy, 
we treated the 5 PD or FD time-point data for each AMM subject as repeated measurements. The analysis of such 
subject-averaged data revealed an interplay between global DNA methylation, post-prandial state and BMI. First, 
global DNA methylation was significantly higher in PD relative to FD when comparing normal weight or obese 
AMM of the two sets (Fig. 3). Furthermore, within FD or PD, global DNA methylation was significantly lower 
in overweight and obese, compared to normal weight subjects. Weak (p = 0.04) differences between overweight 
and obese subjects were observed and only in the FD set. The extreme global DNA methylation differences and 
levels shown in Fig. 3 and in the results below, although counterintuitive have been reported in several studies 
Figure 2. DNA methylation trends across the sampling period in AMM. Average and SD for n = 4 subjects 
per time point are shown. Open circles: normal weight; solid squares: overweight; open squares: obese. The 
arrows indicate the approximate time of the meal consumption in PD.
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(see for example17–19). As for metabolic parameters, an initial approach by Pearson’s correlation analysis revealed 
that VLDL and TG were significantly and inversely correlated with global DNA methylation in both the FD and 
PD sets (Supplementary Table 5). To account for a possible delayed response, we compared global DNA meth-
ylation at 6 PM against metabolic variables at the 12 PM blood draw, but correlations were generally weaker 
(Supplementary Table 6).
Although the correlation with total FAs was not significant, the above results suggested that specific compo-
nents of the VLDL FA pool could be associated with global DNA methylation. To explore the potential interplay 
between FAs and DNA methylation, we examined the distribution of FAs across sample groups, according to the 
degree of FA saturation. In order to take the data variability into account, we analysed the complete data point set 
(n = 5 in each time point) for each subject in either FD or PD, i.e. n = 20 observations per BMI group. Normalized 
(% of total FAs) FA data were used. When plotted by global DNA methylation, a clear stratification of FA types 
could be observed despite the fact that data were not subject-averaged, which suggested specific associations with 
both global DNA methylation and BMI (Fig. 4). Both SFAs and MUFAs showed an inverse trend relative to DNA 
methylation, while the opposite was observed for PUFAs. Concomitantly, the data suggested an increase of SFAs 
and MUFAs, and a decrease of PUFAs, respectively, with BMI. PUFAs were clearly stratified by BMI, particularly 
in the PD set.
Figure 3. Global DNA methylation in FD, PD and BMI classes. Datapoints are the four subjects’ averages 
of 5 repeated measurements in each condition. Asterisks above data points indicate the significance of the 
comparison with normal weight subjects within the FD or PD set. Asterisks above the horizontal lines indicate 
the significance of the comparison between FD and PD for the same BMI group. N, OW and OB indicate 
normal weight, overweight and obese subjects, respectively. Significance levels: ***p < 0.001; ****p < 10−4; 
ANOVA and Scheffé's test.
Figure 4. FA type distribution according to BMI and global DNA methylation in AMM. Green, blue 
and red: normal weight, overweight and obese subjects. n = 20 datapoints for each BMI class are shown, 
corresponding to the 5 repeated measurements for each of the 4 subjects in each BMI class.
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Based on the above data, we undertook a multiple linear regression analysis to assess the association of DNA 
methylation with normalized (% of total) FAs while adjusting for anthropometric and metabolic variables. The 
analysis was performed in subject-averaged values (n = 12 for either FD or PD). Global DNA methylation was 
significantly associated with PUFAs, but not SFAs or MUFAs, in PD and in FD after adjusting as indicated in the 
Methods section (Table 2). Multiple linear regression analysis within PUFAs revealed a significant positive associ-
ation of global DNA methylation with EPA in both FD and PD. A significant although weaker positive association 
with AA was detected but only in PD. Global DNA methylation was inversely associated with BMI in FD and PD. 
An additional positive association with glucose was detected in PD. Generally, the multiple regression models, 
including FAs and metabolic variables, accounted for a higher portion of global DNA methylation variation 
(60–70%) in AMM compared to LI (compare Table 2 and Table 1).
Akin to the LI cohort, we also tested the associations between FAs and age in AMM. A number of significant 
positive associations (which included both AA and EPA) were consistent in both FD and PD, but none overlapped 
with those identified in the LI cohort (Supplementary Table 7).
Associations with gene-specific DNA methylation. Next, we probed for any trend or associations 
between FAs and the histone deacetylase 4 (HDAC4) promoter or pyruvate dehydrogenase kinase 4 (PDK4) 5′ 
UTR methylation across sampling time in the AMM subjects. These particular genes and genic regions were 
chosen based on previous evidence showing an inverse correlation between expression and the methylation state 
of these regions20–22 (Silva-Martínez et al., in press). Furthermore, HDAC4 and PDK4 show opposite trends in 
methylation and expression in obese individuals20–22 and PDK4 was the most up-regulated gene in response to the 
VLDL-rich lipoprotein-induced DNA hypermethylation in the human monocytic THP-1 cell line5.
For HDAC4, we analysed average methylation data for 2 CpGs located in the distal promoter region, one of 
which showed a ~40% decrease in methylation between 1 and 100 μ M AA-stimulated human cultured THP-1 
monocytes that was associated with an increase in expression (Silva-Martínez et al., in press). In the case of PDK4, 
we analysed average methylation data of five CpGs that mapped within the 5′ UTR region that shows an inverse 
association with expression when methylated in both a CG and non-CG context (Supplementary Figure 1)21. 
Importantly, traditional bisulfite sequencing of this region in two AMM subjects in PD and FD (n = 20) demon-
strated a concordance between the average of bisulfite-sequenced CpGs (n = 35) or non-CpG (n = 83) site 
methylation and the average methylation of the five pyrosequenced CpGs (Pearson’s r = 0.72, p = 3.4 × 10−3 and 
r = 0.51, p = 0.022, respectively), indicating that average methylation data of the latter is representative of the 5′ 
UTR region.
The average methylation data of the 2 (HDAC4) and 5 (PDK4) CpGs sequenced were: 0.62 + 0.17% (FD) and 
0.67 + 0.25% (PD) for HDAC4 and 2.70 + 0.69% (FD) and 3.63 + 2.87% (PD) for PDK4. Similarly to global DNA 
methylation, no significant trend with time could be observed for methylation in either gene (Fig. 2 middle and 
lower panels). However, with respect to variability, PDK4 showed the opposite pattern to global DNA methylation, 
i.e. a ~2-fold higher variability in the normal weight set, compared to overweight and obese (p < 0.001 in both FD 
and PD, Bartlett’s test). Gene-specific differences in methylation levels were also observed. HDAC4 methylation 
was lower in normal weight PD compared to overweight and obese (p = 0.0006 and p = 5.94 × 10−5, respectively; 
ANOVA followed by the Scheffé's post hoc test). The opposite trend, i.e. higher methylation in the normal weight 
set, was observed in FD for PDK4, although only compared to the obese set (p = 0.047). The paired differences 
between the same BMI class sample in FD and PD were not significant. The data therefore hinted at inverse and 
positive relationships of HDAC4 and PDK4 methylation, respectively, with PUFAs, given the relative enrichment 
of the latter in the normal weight set. Indeed, multiple regression analysis revealed that HDAC4 methylation in PD 
and PDK4 methylation in FD was inversely and positively associated with AA, respectively (Tables 3 and 4). PDK4 
methylation showed a positive association with EPA in both FD and PD (Table 4). Similar to global DNA methyl-
ation, the association with EPA was stronger than with AA. The FA models accounted for 25–70% of the respec-
tive DNA methylation variation. Notably, glucose accounted for ~85% of HDAC4 methylation variation in FD. 
Examples of the methylation trend at the two loci in two representative samples with extreme AA levels are shown 
in Supplementary Figure 1. Despite the obvious stratification by BMI class (Fig. 2), only a marginal association of 
HDAC4 methylation with BMI was detected in our multiple regression model in PD (Supplementary Table 2.5).
Sample Variable Beta t p adjusted R2
PD
PUFAs 0.0214 3.7356 0.0047 0.4815¶
BMI − 0.1611 − 3.1200 0.0268
0.7437§
glucose 0.0849 3.2093 0.0237
C20:4 (AA) 0.1118 4.2941 0.0013
C20:5 (EPA) 0.7000 6.1371 0.0001
FD
PUFAs 0.0146 2.5549 0.0309 0.4273¶
BMI − 0.0862 − 2.9481 0.0163
0.6235§
C20:5 (EPA) 1.1339 4.2449 0.0017
Table 2.  Significant associations with global DNA methylation (dependent variable) in the AMM subjects. 
¶SFA/MUFA/PUFA model. §Individual PUFA model. Beta values indicate the change in % 5mdC per one-point 
increase in FA (%), BMI or glucose (mg/dl). Non-significant associations are shown in Supplementary Table 2.4.
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Associations between FAs, weight or BMI. In order to better understand the interplay between FAs, 
DNA methylation and the metabolism, we asked whether any specific associations of FAs with body weight 
existed in LI or AMM. In LI, three FAs were inversely associated with the weight at birth or the normalized weight 
gain (Supplementary Table 8). In all cases, the portion of weight variance accounted for by these associations was 
~17% or less. In AMM, significant associations were observed for the SFA C16:0 (palmitic acid) and the MUFA 
C16:1 (palmitoleic acid) and for the SFA C18:0 (stearic acid) in FD (Supplementary Table 9). None of these 
FAs was significantly associated with global or gene-specific DNA methylation (Tables 1 and 2). In summary, 
associations with weight involved different FAs in LI, PD and FD, and the same FA (C16:0) showed inconsistent 
associations between LI and AMM.
Discussion
Although the majority of DNA methylation profiles which are established during early development, are faith-
fully inherited following replication, several evidences show that the DNA methylation state of specific genes or 
repetitive sequences is altered, albeit modestly, in response to metabolic changes such as exercise23–25, alterations 
in body weight following RYGB22,26–28 and dietary intervention13,14,29–33. Similarly, our data show that variation 
in DNA methylation between two different metabolic states, postprandial and fasting, occurs both in lean, over-
weight and obese individuals. As for post-prandial time-dependent global or gene-specific DNA methylation 
trends, our survey did not clearly show any consistently identifiable profile. Thus, the data do not support the 
occurrence of diet-driven, short-term intra-individual global DNA methylation oscillations in an 8-hour time 
window. Rather, the significant increase in global DNA methylation in the PD sets at least in the two extreme BMI 
groups compared to FD, suggests dietary effects that are subtle and diluted over time.
We detect an inverse association between BMI and global DNA methylation, which includes potential meth-
ylation changes in high copy number repetitive elements, such as LINE and Alu. Several studies have used the 
methylation state of such repeated elements to probe for associations between BMI and DNA methylation, but in 
the majority of cases no significant associations or trend, was uncovered (reviewed by van Dijk an colleagues34). 
Similarly, genome-wide obesity-relevant studies of DNA methylation using methylation arrays show either a net 
increase26 or decrease in methylation35–38 of specific genes in obese relative to lean individuals. While the under-
lying heterogeneity of these results is not understood, several factors such as gender and race/ethnicity39–42, folate 
and homocysteine levels41,43, aging and nutritional intake44 are all known to affect methylation. Notwithstanding 
these variables, our results show that EPA and AA are significantly associated with DNA methylation in two 
cohorts of distinct diet and post-natal developmental stage, independent of BMI and sex. The consistency and rel-
evance of those associations are further evidenced by the fact that global DNA methylation was measured by two 
entirely different methods (the MethylFlash™ ELISA-based system and an HPLC-based technique) in different 
laboratories and sample types - i.e. whole blood in LI and PBMCs in AMM. Although we also uncovered associ-
ations of specific FAs with age and weight, none were consistent across cohorts or related to DNA methylation. 
Thus our data do not support the idea that specific fatty acids mediate age-related changes in DNA methylation.
Collectively, our data show that whole blood levels of selected PUFAs, which are lower in obese individuals, 
are important determinants of both global and gene-specific methylation profiles. To our knowledge this is a 
little explored topic, the only related report describing an inverse association between PUFAs and BMI in healthy 
obese individuals45. Interestingly, a recently published DNA methylome study in twins revealed that only twins 
discordant for both BMI and elevated liver fat differed significantly in leukocyte DNA methylation, with the 
heavier twin showing decreased levels of methylation in addition to lower levels of the PUFA linoleic acid46. These 
data point to an important association between liver lipid metabolism and blood methylation profiles. Indeed, the 
above discussed discrepancies between BMI and DNA methylation may in part be explained by the observations 
that elevated liver fat content, a characteristic of non alcoholic dependant fatty liver disease, is present in many, 
but not all obese individuals and disproportionately in Hispanics, predominantly of Mexican origin47.
Sample Variable Beta t p adjusted R2
PD C20:4 (AA) −0.0664 −2.0042 0.0464 0.2524
FD glucose 0.0397 4.7465 0.0177 0.8581
Table 3.  Significant associations with HDAC4 promoter methylation in the AMM subjects. Beta values 
indicate the change in % 5mdC per one-point increase in percent FA. Non-significant associations are shown in 
Supplementary Table 2.5.
Sample Variable Beta t p adjusted R2
PD C20:5 (EPA) 4.1432 2.2777 0.0499 0.3140
FD
PUFAs 0.0373 2.7347 0.0291 0.6990¶
C20:4 (AA) 0.2411 2.9776 0.0155
0.5828§
C20:5 (EPA) 1.6523 2.6578 0.0261
Table 4.  Significant associations with PDK4 5′UTR methylation (dependent variable) in the AMM 
subjects. ¶SFA/MUFA/PUFA model. §Individual PUFA model. Beta values indicate the change in % 5mdC per 
one-point increase in percent FA. Non-significant associations are shown in Supplementary Table 2.8.
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The present analysis included two genes, HDAC4 and PDK4, both of which are known to be important regu-
lators of glucose and fatty acid metabolism23,26,48. In particular, we found that the opposite associations of HDAC4 
and PDK4 methylation with PUFAs are consistent with the previously published methylation and expression 
trend of these two genes with BMI20,22. However, we have recently shown that AA and the MUFA oleic acid 
have distinct, wide-spread, albeit small effects on a large number of genes in a monocytic THP-1 cell line, some 
of which are associated with changes in gene expression (Silva-Martínez et al., in press). We predict that some 
of the target genes identified in the above described study will show BMI-dependant changes in methylation 
and expression, although the effects may be subtle. In line with this view, DHA and EPA intake Yup’ik Alaskan 
natives, measured using red blood cell δ 15N, identified several biologically relevant CpGs sites that showed an 
robust association between methylation and DHA and EPA intake, of which the majority showed increased levels 
of methylation49. Furthermore, dietary supplementation with n-3 PUFA in pregnant women is associated with 
a 1% increase in infant LINE-1 methylation and alterations in promoter levels of immune response genes IFNγ 
and IL1330. Similarly, n-3 PUFA or fish oil supplementation in adult humans also lead to modest alterations in 
promoter regions of genes involved in PUFA metabolism31 or genes previously known to be regulated by n-3 FA, 
the latter of which included PDK432.
The associations uncovered here may reflect a direct effect of FAs on the DNA methylome. In support of this 
view, our recent work identified PPAR-alpha and SIRT1 as mediators of AA-induced DNA hypermethylation in 
cultured monocytes (Silva-Martínez et al., in press). In addition, functional annotation analysis of the top 150 
genes (ranked by the number of differentially methylated CpGs between the 100 and 1 μ m AA concentrations/
number of probes present in Illumina’s Infinium HumanMethylation450 BeadChip platform for a given gene) 
revealed a significant enrichment for the G protein-coupled receptor signalling pathway that are known to be 
activated by specific fatty acids50. On the other hand, a complex metabolic network links the availability of methyl 
group donors, lipid metabolism genes and FA synthesis, in which the hepatic metabolic activity plays a central 
role (reviewed by da Silva and colleagues)46,51,52. Interestingly, hyperhomocysteinaemia, an imbalance of the folate 
cycle that often results in DNA hypomethylation, is associated with low levels of AA in mice53. These studies sug-
gest that the positive association between PUFAs and DNA methylation reflects a balanced cellular metabolism 
in which the correct methyl donor availability maintains physiological levels of DNA methylation and the correct 
expression of AA-generating enzymes such as FADS2. To our knowledge, no information is available on the 
opposite mechanism, i.e. a direct effect of FAs on methyl donor availability.
We also document a complex interplay between BMI, high-fat diet (PD set) and DNA methylation. On the 
one hand, global DNA methylation decreases with BMI in both PD and FD sets, yet an increase is observed in PD 
relative to FD. It is tempting to speculate that the data reflect opposite short-term and long-term effects of high 
fat diet. This view is supported by the documented induction of DNA hypermethylation by short-term high-fat 
diet in humans and mice, and by a 24- exposure of cultured cells to lipoproteins or selected FAs4,5,13,54 (and 
Silva-Martínez et al., in press) whereas a 6 year-long high-fat diet induced the opposite response in leukocytes 
in a primate model55. We speculate that the transient BMI-independent increase in DNA methylation observed 
in PD relative to FD reflects a genomic response to an acute increase in nutrient-activated pathways relevant to 
glucose and lipid metabolism such as the described pathways involving G-protein coupled signalling and PPARs. 
Oppositely, the reduced levels of DNA methylation characteristic of overweight and obese individuals may be 
related to structural changes in liver morphology and/or lipid metabolism following prolonged hyperlipidaemia.
Both global and gene-specific DNA methylation was more strongly associated with EPA than with AA. Yet, 
EPA circulating levels were 2–3-fold lower than other PUFAs such as docosahexaenoic acid in our samples, in 
accordance with previously reported data56, thus underlining EPA’s significant biological importance. EPA and 
AA are products of essential FA metabolism, therefore are potentially relevant to understand the epigenetic effects 
of dietary components in human health and disease. Both FAs are involved in inflammation resolution57. The 
n-3 PUFA EPA has been long regarded as a protective FA, particularly in the light of the favourable cardiometa-
bolic effects of fish oil (see Kromhout and De Goede for a recent review58). A growing literature documents the 
regulation of specific signalling pathways and gene-specific methylation by EPA in vitro59,60. At chromatin level, 
EPA decreases the expression of polycomb group proteins that alter histone posttranslational histone modifica-
tions at specific loci61. As for AA, this PUFA has complex biological functions, ranging from the participation in 
inflammation resolution mentioned above, to being a precursor of inflammatory mediators. The impact of AA 
on cardiovascular health and other inflammation-related disorders has not yet been conclusively established62. 
We showed that AA induces global DNA hypermethylation in human THP-1 monocytes (Silva-Martínez et al., in 
press), in accordance with the positive association detected in the present study.
In summary, we demonstrate for the first time a strong association of DNA methylation with EPA and AA 
in two populations of different age and developmental stage. In addition, this study replicates in human subjects 
in vivo data previously obtained in cell lines, underlining the significance of the latter models to mechanisti-
cally link EPA and AA to DNA hypermethylation. Further work is needed to correct important caveat in this 
study, such as the relatively small sample size and missing information on potentially diet-dependent blood cell 
type-specific DNA methylation profiles.
Methods
LI cohort. Infants were recruited at the public paediatric centre “Secretaría de Salud UIMAPS San Felipe de 
Jesús”, in the city of León, state of Guanajuato, in central Mexico, which provides routine infant health checks. 
Inclusion criteria were exclusive breast-feeding or sporadic use of formula milk (reported in 4 out of 49 infants), 
absence of any mother’s or infant’s chronic or acute diseases, normal birth weight, uncomplicated pregnancy and 
delivery. The requirement for predominant breast-feeding aimed at increasing sample homogeneity. All partici-
pating mothers gave their informed consent to the procedure and the ethical committee of the hosting institution 
approved the protocol, which included a presentation of the main results of the study to the mothers and medical 
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personnel. The methods were carried out in accordance with the approved guidelines. The LI cohort and AMM 
(see below) procedures were conducted in accordance with the WMA’s 2013 Declaration of Helsinki guidelines.
AMM group participants. Volunteers were recruited among the caretaker personnel of the University 
of Guanajuato in central Mexico and selected according to metabolic profiling prior to the project. The inclu-
sion criteria were: male sex; age >25 years; normal fasting glucose and total cholesterol (TC) (<100 mg/dL and 
< 250 mg/dL, respectively); normal blood pressure (BP; range: 90–139/60–89 mmHg). Subjects were grouped 
according to body mass index (BMI) in normal, overweight and obese (n = 4 in each group). The inclusion of 
males only was aimed at simplifying the statistical analysis and increasing the chances of detecting any effects in 
the light of the documented sexual dimorphism of obesity and cardiovascular risk63,64. All participants gave their 
informed consent to the procedure and the Ethical Committee of the Department of Medical Sciences, University 
of Guanajuato, approved the protocol. The methods were carried out in accordance with the approved guidelines.
Blood samples. In the LI cohort, 500 μ L of arm venous blood were drawn in an EDTA-coated tube and 
immediately frozen. In the AMM group, ~10 mL peripheral blood were obtained in two different days apart by 
at least one week. On both days, the subject was asked to fast for 12 h and to abstain from exercise in the 48 h 
period prior to the first blood draw. On either day, venous blood was drawn 5 times at 2 h intervals starting at 10 
AM. On one day (post-prandial day; PD data set), the subject consumed a single standard meal representative 
of the Western diet (one each of McDonald’s McChicken, medium-size fries, medium-size coke) immediately 
after the first blood draw at 10 AM. The 10 AM blood draw data are therefore considered as basal for that day. 
On the other day (fasting day; FD dataset), the subject maintained fasting throughout the blood draw period and 
was offered a small meal after the last (6 PM) blood draw. The rationale for including a complete fasting sample 
set was that it could allow accounting for circadian rhythm-related65 and blood cell type composition-related 
effects. Blood cell-type composition effects would be attenuated in intra-subject comparisons - i.e. between PD 
and FD - by the similar habits the subjects were required to adhere to in the 48 h previous to sampling. Blood 
cell-type composition may well contribute to inter-individual differences in FA profiles, global DNA methylation 
levels or other parameters, but correcting for that variable would mask genuine markers of prandial or metabolic 
state, whatever their underlying biological origin. Water was allowed ad libitum throughout the procedure in all 
cases. A schematic diagram of the procedure is shown in Fig. 1. Peripheral blood mononuclear cells (PBMCs) 
were obtained from ~5 mL EDTA-anticoagulated blood by centrifugation in Ficoll-Paque (GE Healthcare Life 
Sciences) according to the manufacturer’s recommendations. PBMCs and the remaining whole blood samples 
were stored at − 80 °C in 200 μ L aliquots until processed.
Blood lipid and FA determination. Standard enzymatic-colorimetric methods (Spinreact) were used to 
determine triglycerides (TG), high-density lipoproteins (HDL) and TC levels according to the manufacturer’s 
instructions. Low-density lipoproteins (LDL) and VLDL levels were determined using the Friedewald equation 
(LDL = TC-HDL-(TG/5 = VLDL)66.
Whole blood total (i.e. esterified and free) FAs were determined in LI and AMM with two different methods 
by two different research groups in different laboratories at two different time points. For AMM, 500 μ L whole 
blood aliquots were frozen-lyophilized. One mL 0.5 M NaOH in methanol and 10 μ L methyl-nonadecanoic acid 
(5 mg/mL) as an internal standard, were added and incubated at 90 °C for 1 h. After cooling to room temperature, 
1 mL BF3 in methanol was added and incubated at 90 °C for 30 min and cooled again at room temperature. After 
transferring to a clean vial, 2 mL deionized water and 4 mL hexane were added, the organic phase was collected 
and the solvent evaporated with a stream of nitrogen. Dried sample were resuspended in 400 μ L isooctane to be 
analysed by GC/IEMS. Samples were analysed in a Gas Chromatograph (Agilent Technologies 7890A) using a 
capillary column Zebron ZB-WAX (30 m × 250 μ m × 0.25 μ m) coupled to an Electron Impact Mass Spectrometer 
(Agilent Technologies 5975C). Oven temperature program was follows: initial temperature 50 °C during 3 min, 
then increasing at a rate of 10 °C/min to 250 °C and maintained for 20 min. Injector temperature of 220 °C was 
maintained constant. Helium 2 ml/min was use as carrier gas. Sample was injected with a 10:1 split. MSchem 
software was used to collect m/z data and NIST MS Search Software to compare the mass spectra and reten-
tion time vs. NIST 2011 database (National Institute of Standards and Technology Mass Spectra Database U.S. 
Department of Commerce) for the identification of the fatty acids methyl esters. For LI, FAs were determined as 
described above but using gas chromatography with flame ionization detector using a HP-88 capillary column 
(100 m × 0.25 mm, film 0.20 μ m, Agilent Technologies, USA). Methyl tridecanoate was used as the internal stand-
ard, five point calibration was performed using a FAMEs standard mix containing esters of C8-C22 FAs (Supelco 
reference number 18920) with addition of AA. The identification of FAs in blood extracts was based on their 
retention times.
Global DNA methylation assays. Whole blood (0.2 mL) or PBMC DNA was extracted by using the 
DNeasy Blood & Tissue Kit (QIAGEN) according to the manufacturer’s instructions and was quantified using 
SYBR Green I (Sigma-Aldrich). Total 5-methyldeoxycytosine (5mdC) was determined with the MethylFlash™ 
Methylated DNA Quantification Kit, colorimetric (Epigentek) according to the manufacturer’s instructions or by 
a HPLC-based method67 for AMM or LI, respectively.
AA-stimulated human THP-1 monocytes. THP-1 cells were stimulated with 1, 10 or 100 μ M 
BSA-conjugated AA for 24 h as described (Silva-Martínez et al., in press). Genome-wide methylation data were 
obtained with the Infinium HumanMethylation450 BeadChip platform (Illumina) and are publicly available in 
NCBI’s Gene Expression Omnibus68 with the accession number GSE67331.
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Gene-specific DNA methylation and expression. DNA methylation in the 5′ UTR of pyru-
vate dehydrogenase kinase, isozyme 4 (PDK4) and the histone deacetylase 4 (HDAC4) distal promoter 
was measured by pyrosequencing in bisulfite-treated DNA (EZ DNA Methylation™ , Zymo Research), 
using the PyroMark Q96 ID (Qiagen) according to the manufacturer’s instructions. The following prim-
ers designed with the PyroMark Assay Design software were used for PDK4 pyrosequencing (5′ to 3′ ): 
GGTGGGAAGATTTGAATTTGAA and AAAACTACTCRAAACAAAACCTAATTCC (PCR primers; R 
indicates A or G); GGTATTTTTAAATTTTAGTTTAGG (sequencing primer). The corresponding primers for 
HDAC4 were: TGGGAGGTTTGTGTTGAGTT and CACCACCAAAAAAATAACCACTA (PCR primers); 
TGGTTGTTAGTAGGTG (sequencing primer). Supplementary Figure 1 schematically shows the sequenced 
loci and primer positions. For profiling the PDK4 5′ UTR by traditional bisulfite-modified DNA sequencing, the 
primers AAATGTTTTATTTTTYGGGGTA (forward; Y indicates C or T) and AACTCCTCCTATTTAAAACT 
(reverse) were used. Fifteen-twenty clones were sequenced per sample. HDAC4 expression was assessed by reverse 
transcription-PCR with the primers GTGGGTTTCAACGTCAACATG and GTGACACGGGAAAGTTTCTTG.
Statistical analysis. Groups were compared by ANOVA followed by Scheffé’s post hoc test, while the 
Wilcoxon test was used in paired comparisons between experimental days. Correlations were measured with 
the Pearson’s r test. Associations between DNA methylation and FAs were assessed by best fit multiple regres-
sion analysis with global or gene-specific DNA methylation as dependent variable. In the case of the LI cohort, 
percent-normalized total FAs, sex, age at sampling, weight at birth, birth-to-sampling weight change/day (i.e. 
normalized weight gain) were the predictors. In the case of AMM, predictor variables were age, BMI, lipoproteins, 
TG, cholesterol, total FAs, percent-normalized individual FAs or grouped by degree of saturation and BP. Multiple 
regression analysis was then repeated with the individual members of the FA saturation class that was significantly 
associated in the first analysis and all other significantly associated variables as predictors. Dependent varia-
bles for all other multiple regression models are indicated in the Results section. Differences in variability (SD) 
between groups were tested by the Bartlett’s test. Tests were performed with the STATISTICA software (StatSoft) 
or with the StatPlus (AnalystSoft) MS Excel plug-in.
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